Physician

Pathology

Jinsong works in the field of Pathology. He studied medicine at NYU School of Medicine. Jinsong is a published doctor. He has 40 papers published. The most current publication "Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases." Jinsong accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
• Erythropoietin Stimulates Tumor Growth via EphB4.
• Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.
• MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
• Hematogenous metastasis of ovarian cancer: rethinking mode of spread.
• The Role of Choroid Plexus In IVIG-induced Beta-Amyloid Clearance.
• Antagonism of Tumoral Prolactin Receptor Promotes Autophagy-Related Cell Death.
• Notch3 Pathway Alterations in Ovarian Cancer.
• Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel.
• Role of Focal Adhesion Kinase in Regulating YB-1-Mediated Paclitaxel Resistance in Ovarian Cancer.
• TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment.
• CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer.
• CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.
• Interleukin-1? Promotes Ovarian Tumorigenesis through a p53/NF-?B-Mediated Inflammatory Response in Stromal Fibroblasts.
• Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.
• Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer.
• Discovery of INT131: A selective PPAR? modulator that enhances insulin sensitivity.
• Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo.
• Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1signal.
• RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.
• Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells.
• Tumor stroma as targets for cancer therapy.
• Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.
• Effects and possible mechanisms of acupuncture at ST36 on upper and lower abdominal symptoms induced by rectal distension in healthy volunteers.
• Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.
• Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma.
• Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy.
• Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread.
• A Fraction of CD133+ CNE2 Cells Is Made of Giant Cancer Cells with Morphological Evidence of Asymmetric Mitosis.
• Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
• Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.
• Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.
• 2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
• iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development.
• Chondroblastoma of calcaneus.
• Transformation of the human ovarian surface epithelium with genetically defined elements.
• VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer.
• Mucinous borderline tumor involving fallopian tube: case report and review of the literature.
• Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.

Schools

---

• Shanghai College Of Traditional Chinese Medicine

• New York Clin Med Center

Doctors Specialties

---

• Anatomic Pathology
• Pathology

Accepted Insurances

---

Education

---

• NYU School of Medicine
• Shanghai Medical University

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1043319908
Last Name Of The Provider	LIU
First Name Of The Provider	JINSONG
View All

Similar Doctors

---

	Dr. Mary R. Schwartz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rhonda P. Ghorbani, MD This Doctor is OpenDoctor Recommended.
	Dr. Bojana Djordjevic, MD
	Dr. Michael M. Ittmann, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christopher M. Leveque, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael W. Lieberman, MD
	Dr. Anna E. Sienko, MD This Doctor is OpenDoctor Recommended.
	Dr. Ena E. Mocega, MD This Doctor is OpenDoctor Recommended.
	Dr. Cesar A. Moran, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Adriana Olar, MD This Doctor is OpenDoctor Recommended.
	Anupma Nayak, MB

---

Doctor Directory | TOS | twitter | FB | Angel | blog